Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02862275
Title Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer
Recruitment Active, not recruiting
Gender both
Phase Phase 0
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.